Liver and Biliary Tract Disease in Patients with Coronavirus disease-2019 Infection
- 4 October 2022
- journal article
- research article
- Published by Elsevier in Gastroenterology Clinics of North America
- Vol. 52 (1) , 13-36
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19New England Journal of Medicine, 2020
- Liver injury in COVID-19: management and challengesThe Lancet Gastroenterology & Hepatology, 2020
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational studyThe Lancet Respiratory Medicine, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaNew England Journal of Medicine, 2020
- Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington StateJAMA, 2020
- Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive studyThe Lancet Infectious Diseases, 2020
- Liver injury during highly pathogenic human coronavirus infectionsLiver International, 2020
- Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus diseaseChinese Medical Journal, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Cholangiocyte pathobiologyNature Reviews Gastroenterology & Hepatology, 2019